Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical, Inc.    ISRG

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Intuitive Surgical, Inc. : Intuitive Surgical 1Q Profit Up 38% On Strong Revenue

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2012 | 12:14am CEST

--Intuitive Surgical tops first-quarter sales and earnings estimates

--Sales of da Vinci systems, procedure growth, fuel gains

--Company raises full-year guidance for sales, procedure growth

(Updates throughout with details on results and outlook)

 
   By Jon Kamp 
   Of  
 

Intuitive Surgical Inc.'s (ISRG) first-quarter earnings rose 38%, beating Wall Street expectations behind climbing sales of the company's da Vinci robotic-surgery machines and growth in procedures.

The Sunnyvale, Calif., company boosted its full-year forecasts for both revenue and procedure growth following the strong quarterly report. Shares--which are trading near all-time high levels and have climbed 18% on the year through Tuesday's close--rose 5.8%, to $576.98 in after-hours trading.

The company's motion-capture robots, which have been heavily used for cancer-treating surgeries, such as hysterectomies and prostate removal, have remained in strong demand despite continued economic turbulence and some sluggishness in Europe. The company sold 140 machines in the recent quarter, up 20 from a year ago, and posted 29% growth in procedures.

The company saw strong growth in both general-surgery and gynecological procedures, Chief Executive Gary Guthart said on a conference call with analysts. Newly introduced da Vinci instruments also helped fuel rising sales.

Intuitive Surgical reported a profit of $143.5 million, or $3.50 a share, up from $104.1 million, or $2.59 a share, a year earlier. Revenue increased 28%, to $495.2 million.

Analysts polled by Thomson Reuters most recently projected earnings of $3.14 on revenue of $464.7 million.

Gross margin edged up to 71.9% from 71.8%.

Revenue from instruments and accessories climbed 32%, reflecting growth in da Vinci procedures and the roll-out of new products. Revenue from service deals for da Vinci machines jumped 27%. Systems revenue, reflecting newly sold machines, grew 24%.

Da Vinci systems sold for nearly $1.5 million, on average, in the recent quarter.

Despite the overall strong sales, company officials said system sales in Europe were disappointing and below historical trends. They indicated the company is working to bolster its marketing efforts there.

"European system sales reflect a challenging economic environment, however, we are also taking steps to improve our execution," Chief Financial Officer Marshall Mohr said on the conference call.

Looking ahead, Intuitive Surgical now anticipates revenue growth of 19% to 21% this year, up from the company's prior 17% to 19% forecast. The company's new guidance calls for procedure growth of 25% to 27%, up from the prior 24% to 26% target.

Analysts had forecast, on average, sales growth of about 18% this year.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; [email protected]

--Tess Stynes contributed to this article.

Order free Annual Report for Intuitive Surgical, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US46120E6023 or call +44 (0)208 391 6028

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL, INC.
05/12 Intuitive Surgical Reports New Employee Option Grants for May 2017
05/11 INTUITIVE SURGICAL : Patent Issued for Retraction of Tissue for Single Port Entr..
05/11 INTUITIVE SURGICAL : Researchers Submit Patent Application, "Surgical System Inc..
05/11 INTUITIVE SURGICAL : Patent Application Titled "Ratcheting for Master Alignment ..
05/05 INTUITIVE SURGICAL : Sources Sought Notice - J-- Service repair Intuitive endosc..
05/05 INTUITIVE SURGICAL : Combine Solicitation - One-time repair/replace service
05/02 INTUITIVE SURGICAL : Da Vinci X is designed to get robotic surgery systems into ..
04/27 INTUITIVE SURGICAL : Receives CE Mark for Latest da Vinci Robotic-Assisted Surgi..
04/26 INTUITIVE SURGICAL, INC. (NASDAQ : ISRG) Files An 8-K Departure of Directors or ..
04/26 INTUITIVE SURGICAL RECEIVES CE MARK : New da Vinci X™ Surgical System pro..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
05/15DJMARKET SNAPSHOT : Stock Market Sets Fresh Records As Oil Rallies
05/15 Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
05/17 GAAP-BASED RETURN ON INVESTED CAPITA : Explanation And Examples
05/16 Premarket analyst action - healthcare
05/04 Best-Performing Stocks On Earnings This Season
04/26 Intuitive Surgical's new da Vinci X CE Mark'd
04/24 Medical tech on the move after C.R. Bard sale
Advertisement
Financials ($)
Sales 2017 2 965 M
EBIT 2017 1 194 M
Net income 2017 769 M
Finance 2017 2 132 M
Yield 2017 -
P/E ratio 2017 43,58
P/E ratio 2018 37,45
EV / Sales 2017 10,4x
EV / Sales 2018 9,09x
Capitalization 33 048 M
More Financials
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Full-screen chart
Technical analysis trends INTUITIVE SURGICA...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 869 $
Spread / Average Target -3,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Alan J. Levy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL, IN..41.45%32 863
THERMO FISHER SCIENTIF..21.78%67 329
DANAHER CORPORATION7.85%57 550
BOSTON SCIENTIFIC CORP..23.30%36 700
PHILIPS9.45%33 178
ILLUMINA, INC.36.61%25 591
More Results